The increased production and activation of TGF-β is observed in immune defects associated with autoimmune diseases, susceptibility to opportunistic infections, and fibrotic complications in diseases with chronic inflammation, including IBD. The gene discussed is TGFB1; the disease is inflammatory bowel disease.